InvestSMART

MedAdvisor Limited (ASX: MDR) - Announcements

Current share price for MDR : $0.022 0.002 (10%)+

ASX company news and announcements for MedAdvisor Limited (MDR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MedAdvisor Limited (MDR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MedAdvisor Limited (MDR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MedAdvisor Limited (MDR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Q1 FY24 MDR Quarterly Update 30 Oct 2023 8:29AM $0.185 $0.022 fallen by 88.11%
- MedAdvisor Solutions 2023 Notice of Meeting 27 Oct 2023 9:42AM $0.205 $0.022 fallen by 89.27%
- MedAdvisor 2023 Annual General Meeting 27 Sep 2023 10:28AM $0.225 $0.022 fallen by 90.22%
- Application for quotation of securities - MDR 26 Sep 2023 9:38AM $0.220 $0.022 fallen by 90%
- MedAdvisor Solutions FY23 Full Year Presentation 7 Sep 2023 8:21AM $0.210 $0.022 fallen by 89.52%
- MedAdvisor FY23 Full Year Results Investor Briefing 30 Aug 2023 8:31AM $0.210 $0.022 fallen by 89.52%
- MDR delivered strong financial results in FY23 30 Aug 2023 8:27AM $0.210 $0.022 fallen by 89.52%
- MDR Appendix 4E and FY23 Annual Report 30 Aug 2023 8:20AM $0.210 $0.022 fallen by 89.52%
- MedAdvisor Corporate Governance Statement 30 Aug 2023 8:14AM $0.210 $0.022 fallen by 89.52%
- MedAdvisor Appendix 4G 30 Aug 2023 8:12AM $0.210 $0.022 fallen by 89.52%
- Update regarding unquoted securities 16 Aug 2023 5:34PM $0.225 $0.022 fallen by 90.22%
- Notification regarding unquoted securities - MDR 16 Aug 2023 5:05PM $0.225 $0.022 fallen by 90.22%
- Application for quotation of securities - MDR 4 Aug 2023 1:32PM $0.230 $0.022 fallen by 90.43%
- Application for quotation of securities - MDR 2 Aug 2023 10:42AM $0.230 $0.022 fallen by 90.43%
- 4C Q4 FY23 Medadvisor Quarterly Update - 31 July 2023 31 Jul 2023 8:59AM $0.220 $0.022 fallen by 90%
- Change in substantial holding 19 Jul 2023 2:13PM $0.235 $0.022 fallen by 90.64%
- Notification regarding unquoted securities - MDR 7 Jul 2023 11:01AM $0.220 $0.022 fallen by 90%
- MDR undertakes strategic review 22 Jun 2023 9:51AM $0.230 $0.022 fallen by 90.43%
- Initial Director's Interest Notice - Kate Hill 29 May 2023 11:05AM $0.250 $0.022 fallen by 91.20%
- Initial Director's Interest Notice - Brett Magun 29 May 2023 11:00AM $0.240 $0.022 fallen by 90.83%
- MedAdvisor Strengthens Board 26 May 2023 12:01PM $0.220 $0.022 fallen by 90%
- Application for quotation of securities - MDR 24 May 2023 10:11AM $0.230 $0.022 fallen by 90.43%
- Change in substantial holding 17 May 2023 4:31PM $0.210 $0.022 fallen by 89.52%
- Notification regarding unquoted securities - MDR 1 May 2023 9:57AM $0.235 $0.022 fallen by 90.64%
- Application for quotation of securities - MDR 1 May 2023 9:42AM $0.235 $0.022 fallen by 90.64%

176 - 200 of 761 results

Page 8 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.